Applied DNA Sciences, Inc. | Finanzwire

Basculer en Français

10037	Companies
204503	Keywords
134830	Articles
108465	Press releases

Headlines Articles Press releases Applied DNA Sciences, Inc.

Home
Companies
Applied DNA Sciences, Inc.

PRESS RELEASE

published on 02/08/2024 at 22:05, 2 years 1 month ago

Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
Applied DNA Sciences, Inc. (NASDAQ:APDN) announces Q1 fiscal year 2024 financial results and progress on GMP production capacity for mRNA therapeutics. Projects initial facility capacity to enable up to $15 million Linea IVT revenue annually

Financial Results Applied DNA Sciences MRNA Therapeutics GMP Production Capacity Linea IVT Revenue
PRESS RELEASE

published on 02/05/2024 at 19:00, 2 years 1 month ago

Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024
Applied DNA Sciences, Inc. will release first quarter fiscal 2024 financial results after market close on February 8, 2024, with a conference call for analysts. The company operates in biotechnology developing DNA detection and production technologies

Financial Results Conference Call Biotechnology Applied DNA Sciences DNA Detection
PRESS RELEASE

published on 02/02/2024 at 22:15, 2 years 1 month ago

Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Applied DNA Sciences, Inc. closes registered direct offering of common stock priced at-the-market with institutional investors. Proceeds to be used for therapeutic DNA production services

Registered Direct Offering Institutional Investors Common Stock Applied DNA Sciences DNA Technologies
PRESS RELEASE

published on 01/31/2024 at 14:00, 2 years 1 month ago

Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Applied DNA Sciences, Inc. announces a registered direct offering and a concurrent private placement to certain existing institutional investors. Maxim Group LLC acts as exclusive placement agent

Registered Direct Offering Applied DNA Sciences Securities Purchase Agreements Maxim Group LLC DNA Technologies
PRESS RELEASE

published on 12/14/2023 at 14:00, 2 years 3 months ago

Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
PRESS RELEASE

published on 12/07/2023 at 22:05, 2 years 3 months ago

Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results
PRESS RELEASE

published on 12/05/2023 at 14:30, 2 years 3 months ago

Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023
Applied DNA Sciences, Inc. (NASDAQ:APDN) will release its Q4 and full year 2023 financial results on December 7, 2023, after the market close. A conference call for investors will follow to discuss the results

Financial Results Conference Call Investor Relations Applied DNA Sciences NASDAQ:APDN
PRESS RELEASE

published on 11/28/2023 at 14:30, 2 years 3 months ago

Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
PRESS RELEASE

published on 11/16/2023 at 14:30, 2 years 4 months ago

Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
PRESS RELEASE

published on 11/09/2023 at 15:15, 2 years 4 months ago

Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform

Accesswire

Published on 03/16/2026 at 22:45, 4 hours 51 minutes ago

Copper Road Announces Closing of Financing
Published on 03/16/2026 at 22:30, 5 hours 6 minutes ago

Core Silver Intersects High-Grade Copper-Molybdenum Veins up to 7.31% Cu & 1.01% Mo Confirming Large Porphyry System at Laverdiere
Published on 03/16/2026 at 22:00, 5 hours 36 minutes ago

Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
Published on 03/16/2026 at 21:30, 6 hours 6 minutes ago

Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
Published on 03/16/2026 at 21:00, 6 hours 36 minutes ago

Amdocs Brings AI-Accelerated Application Modernization to Enterprises with NVIDIA

View all ACCESSWIRE

EQS Group

Published on 03/17/2026 at 02:10, 1 hour 26 minutes ago

Clawchain.ai Launches on Chromia to Support the Next Generation of AI Agent Systems
Published on 03/17/2026 at 00:00, 3 hours 36 minutes ago

Cango Inc. Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
Published on 03/16/2026 at 23:07, 4 hours 28 minutes ago

KION brings physical AI into live warehouse operations at GTC 2026 in San José, California
Published on 03/16/2026 at 22:35, 5 hours 1 minute ago

Nscale and Microsoft Announce Collaboration with NVIDIA and Caterpillar to Deliver 1.35GW of NVIDIA Vera Rubin NVL72 GPUs at Flagship AI Factory Campus in West Virginia
Published on 03/16/2026 at 22:25, 5 hours 11 minutes ago

Nscale Acquires American Intelligence & Power Corporation, Creating a Full Stack AI Hyperscaler, Integrated from Energy to Compute

Les Echos

Published on 03/16/2026 at 18:00, 9 hours 36 minutes ago

Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 9 hours 38 minutes ago

Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 9 hours 39 minutes ago

Reporting on share buyback transactions carried out between March 9 and March 13, 2026
Published on 03/16/2026 at 17:45, 9 hours 51 minutes ago

Weekly share buyback
Published on 03/16/2026 at 17:35, 10 hours 1 minute ago

Disclosure of transactions in own shares from March 9 to March 13, 2026

View all LES ECHOS COMFI WIRE